Thomas Raffin

Thomas Raffin has made 22 investments in companies such as: Precision NanoSystem, TrakCel, Nimble Therapeutics, Estech, RareCyte, PneumRx, BioVentrix, Aquaro Histology, AngioScore, LDR Holding, Asuragen, Confirma, Accumetrics, Nivagen Pharmaceuticals, Inc., Freedom Innovations LLC., Althea Technologies, AltheaDx, Medpricer, Specific Diagnostics, Akoya Biosciences, Emerging Therapy Solutions, Carterra.

Location of Thomas Raffin is San Francisco, United States.

The free version of Angel Match provides limited data for Thomas Raffin. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Thomas Raffin is a Venture Partner and he his investment types are: Private Equity Firm.
Thomas Raffin focuses investing in industries such as: Biotechnology, Developer Platform, Medical, Manufacturing, Market Research, Pharmaceutical, Health Care, Life Science, Medical Device, Health Diagnostics, Insurance, Chemical, Therapeutics, Genetics, Information Technology, Robotics.

A short brief about investor:


Past investments

  • Precision NanoSystem
  • TrakCel
  • Nimble Therapeutics
  • Estech
  • RareCyte
  • PneumRx
  • BioVentrix
  • Aquaro Histology
  • AngioScore
  • LDR Holding
  • Asuragen
  • Confirma
  • Accumetrics
  • Nivagen Pharmaceuticals, Inc.
  • Freedom Innovations LLC.
  • Althea Technologies
  • AltheaDx
  • Medpricer
  • Specific Diagnostics
  • Akoya Biosciences
  • Emerging Therapy Solutions
  • Carterra

Social media:

Available after registration.